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remotely using digital images. The second 
approach is called “store and forward”. 
Aims 
3. To demonstrate, by way of example, the 
contribution that Operational Research can 
make to the evidence base and to engage 
Welsh Government officials in service 
optimisation issues e.g. using computer 
modelling methods to simulate services to 
create “what-if” scenarios. 
4. To support the work of the Rural Health 
Implementation Group (RHIG) which 
wanted to ensure the use of Telemedicine 
is maximised across rural Wales and 
beyond.  
5. To identify improvements in services and 
efficiency savings that could be achieved 
by treating dermatology patients using 
teledermatology: 
a. To determine whether “store and 
forward” clinics allow patients to be 
diagnosed and treated in a shorter time 
frame. 
 
 
1. The teledermatology demonstration 
project was one of the projects 
funded under the Welsh 
Government’s Programme to 
Maximise the Use of Existing Data. 
The demonstration project ran 
between 2011 and 2013 and relates 
to the study of teledermatology 
patients attending clinics in Hywel 
Dda Local Health Board between 
2010 and 2012.  
2. Teledermatology is a sub-element of 
telemedicine, which involves using 
technology to support delivery of 
healthcare at a distance. It has two 
forms: supported by a specialist 
nurse, patients may see a consultant 
via videoconference at a local clinic 
instead of travelling to an outpatient 
appointment or consultants may 
diagnose dermatological conditions  
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b. To examine the extent to which a 
patient’s travel distance and the 
associated time and cost can be 
reduced. 
c.     To determine what would happen if 
the consultant dermatologist could 
reduce the current time delay in the 
teledermatology system by looking at 
the electronic referrals more quickly. 
Methodology 
6.  The anonymised data used in this 
demonstration project was provided by 
the Telemedicine Manager for Hywel 
Dda Local Health Board and relates to 
143 “store and forward” patients who 
attended clinics at Aberaeron, 
Aberystwyth and Borth between 7th 
April 2010 and 9th May 2012.  
7. One objective of the teledermatology 
project was to estimate the reductions 
in travel distance and time that were 
achieved by the 143 patients attending 
“store and forward” clinics compared 
with attending an outpatient 
appointment at the hospital. A partial 
postcode was used to estimate patient 
travel distance to the teledermatology 
clinic and the relevant outpatient 
department. The patient travel analysis 
assumed that the patient used private 
transport and not public or patient 
transport. 
8. Computer simulations were developed 
to represent the patient’s treatment 
‘pathway’ using teledermatology and 
the outpatient clinic approach. The 
simulations used data for 123 patients 
attending Aberaeron and Aberystwyth 
clinics, since the Borth Clinic was new 
and the processes still in their infancy. 
The simulation models were 
developed with input from a multi-
disciplinary team - the clinicians 
directly involved with the study, 
academic researchers, and policy 
officials and analysts within the Welsh 
Government.  
9. A cost analysis was undertaken to 
compare teledermatology with the 
outpatient approach. The cost analysis 
was based on the staff costs and 
patient travel costs (including fuel, 
carbon emissions and non-fuel 
operating costs) for each approach 
plus the cost of the camera equipment 
used in the “store and forward” clinics. 
10. The cost analysis considered the direct 
and indirect costs associated with 
travelling to each clinic. The value of a 
patient’s travel time was estimated 
using figures from the Department for 
Transport. Since the patients’ 
employment status was unknown, the 
project used figures that assumed 
patients were not employed. The cost 
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analysis did not include any cost 
associated with patient transport as 
information on the proportion of 
patients using it was not available.  
Key Findings 
11. The project demonstrated that 
significant added value can be gained 
by using data already collected as part 
of delivering a service to inform 
additional research. Lessons were 
learned about working with 
practitioners and about data availability 
and quality.  
12. The study showed that there were 
potential benefits of using 
telemedicine, particularly for patients in 
rural communities.  
13. The study showed that in each of the 
“store and forward” clinics, the patients 
had shorter journeys if they went to 
their local clinic rather than the 
hospital: 
 The 102 patients who attended 
Aberystwyth Clinic saved a combined 
distance of 7,500 miles and a 
combined journey time of 178 hours. 
 The 21 patients who travelled to 
Aberaeron Clinic saved a combined 
distance of 849 miles and a combined 
travel time of 22 hours. 
 The 20 patients who attended Borth 
Clinic saved just over 1,400 miles and 
32 hours of travel. 
 The drive time analysis of the 143 
“store and forward” patients showed 
that on average, a patient saved 75 
miles by attending a local “store and 
forward” clinic instead of an outpatient 
appointment. 
14. The patient travel analysis showed that 
the 19 patients who had their 
appointment via a videoconference at 
Bronglais Hospital rather than 
attending an outpatient appointment at 
Glangwili Hospital reduced their 
combined travel distance by close to 
1,400 miles. 
15. The simulation model results show 
that, using teledermatology, all 123 
“store and forward” patients passed 
through the system in an average 
elapsed time of 92 days. Using the 
outpatient pathway, 98 patients had 
completed their journey through the 
system after 600 days with, for those 
98 patients, an average elapsed time 
in the system of 208 days.  
16. The elapsed time patients spent in the 
outpatient simulation model was 
heavily dependent on the waiting times 
associated with the hospital 
appointment system, particularly for 
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routine patients. When the waiting time 
was reduced to 21 days, the number of 
patients who completed their journey 
through the outpatient system 
increased to numbers similar to those 
found using teledermatology.  
17. In this study, the cost of staff time to 
the Health Board was higher in the 
teledermatology ‘store and forward’ 
service due to the involvement of a 
dermatology specialist nurse as well 
as a consultant dermatologist. The 
cost of camera equipment also 
reduced the apparent cost-
effectiveness of teledermatology but 
the cost per patient will reduce over 
time. The outcome of the cost analysis 
was also heavily influenced by the 
valuation of the patient’s travel time. 
When valued using the Department for 
Transport’s non-working £4 an hour 
estimate, the outpatient approach 
appears more cost-effective; when 
valued at an employed person’s £28 
an hour, teledermatology is more cost-
effective. In reality, the real value of a 
patient’s travel time will lie between 
these two values. For working people 
in Hywel Dda LHB, teledermatology 
would provide a more cost-effective 
means of receiving treatment than the 
outpatient system. 
18. Overall, the project has shown that 
teledermatology through ‘store and 
forward’ clinics can offer improvements 
compared with the outpatient model, 
particularly in rural areas as it offers 
patients: 
 reduced travel time and distance 
and therefore cost. Reduced 
patient travel may have a benefit to 
the environment and thereby 
support the WG’s Sustainable 
Development objectives; 
 a shorter waiting time for an 
appointment; and 
 a shorter elapsed time in the 
system. 
19. Simulation modelling can provide a 
useful virtual representation of a 
system to allow the impacts of different 
service delivery options to be 
compared and can be used to answer 
“what-if” questions such as “what 
would happen to waiting times if 
telemedicine was used more widely?” 
20. The simulation models were presented 
at the Rural Health Implementation 
Group meeting (2012); the feedback 
from the event suggested that the 
visual nature of the simulation models 
helped to engage the audience, which 
included clinicians and policymakers. 
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Next Steps 
21. If additional resources became 
available, the simulation model could 
be improved to include more detailed 
data e.g. the exact dates of GP visits 
and electronic referrals. Further 
research could examine whether 
patients travelled from home or work 
and their means of transport. 
22. Further discussions with consultant 
dermatologists have shown that there 
is potential for teledermatology clinics 
to benefit other dermatology patients 
across Wales. The techniques used in 
this study could be applied to other 
teledermatology clinics in other local 
health boards to demonstrate how 
services vary across Wales and to give 
a clearer picture of how the use of 
teledermatology could be maximized 
throughout Wales.  
23. It should be noted that the uptake and 
success of any service expansion to 
include teledermatology depends on 
the level of investment (personnel, 
equipment) and how it is integrated 
with existing primary and secondary 
care services. 
24. The challenges that emerged during 
the demonstration process and the 
benefits of using OR methods to 
inform service optimisation will be 
explored in more detail in a Lessons 
Learned report, publication of which is 
to follow.  
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